Filing Details

Accession Number:
0001209191-15-056404
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-06-25 17:30:20
Reporting Period:
2015-06-23
Filing Date:
2015-06-25
Accepted Time:
2015-06-25 17:30:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1594864 Juno Therapeutics Inc. JUNO Biological Products, (No Disgnostic Substances) (2836) 463656275
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1591178 Richard Klausner 307 Westlake Avenue North, Suite 300
Seattle WA 98109
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2015-06-23 4,899 $51.98 977,600 No 4 S Direct
Common Stock Disposition 2015-06-23 3,101 $52.77 974,499 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from 51.57 to 52.53. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  2. This transaction was executed in multiple trades at prices ranging from 52.58 to 52.99. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 25, 2015.